I would advise caution on these numbers. The 3500 patients p.a is Japan's estimated TOTAL addressable market. The 1000 patient figure represents a somewhat more realistic figure HOWEVER these things take time to set up, train doctors, distribute and make the market even aware of the product.
I would expect it to be like turning a tap. Medicine is a slow field to change, don't expect much in the first year.
My estimates for Japan only;
Year 1 - 50 to 200 patients
Year 2 - 200 to 500
Year 3 - 500 to 750
Year 4 - 750 to 1000
Remember many people don't have the necessary insurance, can't make the co-payment or simply can't afford it.
Note: Global Data estimates GLOBAL GvHD therapeutics market at $261.6m in 2010, growing to $615.1m in 2018 (msb 29th April 2014). Japan is a tiny fraction of that market.
- Forums
- ASX - By Stock
- MSB
- Revenue from Japan
Revenue from Japan, page-5
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B |
Open | High | Low | Value | Volume |
$1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 99680 | $1.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.16 | 31000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 99680 | 1.150 |
2 | 17000 | 1.140 |
1 | 40000 | 1.125 |
5 | 158332 | 1.100 |
2 | 15000 | 1.095 |
Price($) | Vol. | No. |
---|---|---|
1.155 | 31000 | 2 |
1.160 | 27391 | 2 |
1.170 | 22300 | 2 |
1.175 | 26294 | 3 |
1.180 | 85298 | 3 |
Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |